• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

儿童、青少年和青年非霍奇金淋巴瘤：当前观点。

Childhood, adolescent and young adult non-Hodgkin lymphoma: current perspectives.

机构信息

Departments of Pediatrics, Medicine, Pathology, Microbiology& Immunology, and Cell Biology & Anatomy, New York Medical College, Valhalla, NY, USA.

Division of Paediatric Haemato-Oncology, Princess Maxima Centre for Paediatric Oncology, Utrecht, The Netherlands.

出版信息

Br J Haematol. 2019 Jun;185(6):1021-1042. doi: 10.1111/bjh.15764. Epub 2019 Feb 6.

DOI:10.1111/bjh.15764
PMID:30729513
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6897376/
Abstract

The 6th International Symposium on Childhood, Adolescent and Young Adult (CAYA) Non-Hodgkin Lymphoma (NHL) was held in Rotterdam, Netherlands, 26-29 September, 2018. This summary manuscript is a perspective on the presentations from the plenary scientific sessions, including wellness and survivorship, B-cell NHL, AYA lymphoma, translational NHL biology, lymphoma immunology, bone marrow transplantation and cell therapy, T/Natural Killer cell lymphoma, anaplastic large cell lymphoma, lymphoblastic lymphoma, novel lymphoma therapeutics and Hodgkin lymphoma. The symposium was attended by over 260 registrants from 42 different countries and included young, middle and senior investigators. Finally, the Angelo Rosolen, MD, Memorial Lecture was delivered by Alfred Reiter, MD.

摘要

第六届儿童、青少年和青年（CAYA）非霍奇金淋巴瘤（NHL）国际研讨会于 2018 年 9 月 26 日至 29 日在荷兰鹿特丹举行。这份总结手稿是对全体科学会议演讲的观点，包括健康和生存、B 细胞 NHL、AYA 淋巴瘤、转化 NHL 生物学、淋巴瘤免疫学、骨髓移植和细胞治疗、T/Natural Killer 细胞淋巴瘤、间变大细胞淋巴瘤、淋巴母细胞淋巴瘤、新型淋巴瘤治疗和霍奇金淋巴瘤。该研讨会有来自 42 个不同国家的 260 多名注册参会者参加，其中包括年轻、中年和资深研究人员。最后，Alfred Reiter, MD 发表了 Angelo Rosolen, MD 纪念演讲。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/ff24f8a69543/nihms-1061003-f0017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/d49fa0d244a1/nihms-1061003-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/87bffec06f50/nihms-1061003-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/3419c7f18645/nihms-1061003-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/80362138cbd8/nihms-1061003-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/8a5c2fbf8a76/nihms-1061003-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/895ef2d0390f/nihms-1061003-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/869e1a6f8431/nihms-1061003-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/8776540f71be/nihms-1061003-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/33c9d84fe577/nihms-1061003-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/8f89b548f2d4/nihms-1061003-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/6376240893b8/nihms-1061003-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/05df837c69a1/nihms-1061003-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/52d187e67258/nihms-1061003-f0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/584364d804bc/nihms-1061003-f0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/294c6f8d1516/nihms-1061003-f0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/0318858d51fb/nihms-1061003-f0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/ff24f8a69543/nihms-1061003-f0017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/d49fa0d244a1/nihms-1061003-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/87bffec06f50/nihms-1061003-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/3419c7f18645/nihms-1061003-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/80362138cbd8/nihms-1061003-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/8a5c2fbf8a76/nihms-1061003-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/895ef2d0390f/nihms-1061003-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/869e1a6f8431/nihms-1061003-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/8776540f71be/nihms-1061003-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/33c9d84fe577/nihms-1061003-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/8f89b548f2d4/nihms-1061003-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/6376240893b8/nihms-1061003-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/05df837c69a1/nihms-1061003-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/52d187e67258/nihms-1061003-f0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/584364d804bc/nihms-1061003-f0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/294c6f8d1516/nihms-1061003-f0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/0318858d51fb/nihms-1061003-f0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/6897376/ff24f8a69543/nihms-1061003-f0017.jpg

相似文献

1
Childhood, adolescent and young adult non-Hodgkin lymphoma: current perspectives.儿童、青少年和青年非霍奇金淋巴瘤：当前观点。
Br J Haematol. 2019 Jun;185(6):1021-1042. doi: 10.1111/bjh.15764. Epub 2019 Feb 6.
2
Childhood, adolescent and young adult non-Hodgkin lymphoma: state of the science.儿童、青少年及青年非霍奇金淋巴瘤：科学现状
Br J Haematol. 2016 May;173(4):507-30. doi: 10.1111/bjh.14035. Epub 2016 May 2.
3
Epidemiology, outcome, targeted agents and immunotherapy in adolescent and young adult non-Hodgkin and Hodgkin lymphoma.青少年及青年非霍奇金和霍奇金淋巴瘤的流行病学、结局、靶向药物及免疫治疗。
Br J Haematol. 2019 Jun;185(6):1142-1157. doi: 10.1111/bjh.15789. Epub 2019 Feb 6.
4
Advances in cellular and humoral immunotherapy - implications for the treatment of poor risk childhood, adolescent, and young adult B-cell non-Hodgkin lymphoma.细胞和体液免疫治疗的进展 - 对不良风险儿童、青少年和年轻成人 B 细胞非霍奇金淋巴瘤治疗的影响。
Br J Haematol. 2019 Jun;185(6):1055-1070. doi: 10.1111/bjh.15753. Epub 2019 Jan 6.
5
Paediatric non-Hodgkin lymphoma - perspectives in translational biology.小儿非霍奇金淋巴瘤——转化生物学视角
Br J Haematol. 2016 May;173(4):617-24. doi: 10.1111/bjh.14009. Epub 2016 Mar 24.
6
Treatment and prognosis of mature (non-anaplastic) T- and NK-cell lymphomas in childhood, adolescents, and young adults.儿童、青少年和青年成人成熟（非间变性）T 和 NK 细胞淋巴瘤的治疗和预后。
Br J Haematol. 2019 Jun;185(6):1086-1098. doi: 10.1111/bjh.15772. Epub 2019 Feb 1.
7
Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.奥地利儿童及青少年恶性非霍奇金淋巴瘤——1986年至2000年的治疗结果
Wien Klin Wochenschr. 2002 Dec 30;114(23-24):978-86.
8
Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum.儿童、青少年及青年各年龄段的非霍奇金淋巴瘤。
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):589-597. doi: 10.1182/asheducation-2016.1.589.
9
Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma: state of the science.青少年非霍奇金淋巴瘤和霍奇金淋巴瘤：科学现状
Br J Haematol. 2009 Jan;144(1):24-40. doi: 10.1111/j.1365-2141.2008.07393.x.
10
Paediatric non-Hodgkin lymphoma in low and middle income countries.低收入和中等收入国家的儿童非霍奇金淋巴瘤
Br J Haematol. 2016 May;173(4):651-4. doi: 10.1111/bjh.14030. Epub 2016 Apr 20.

引用本文的文献

1
A nomogram for predicting the cancer-specific death of children and adolescents-onset lymphoma: A SEER database analysis.预测儿童和青少年期淋巴瘤癌症特异性死亡的列线图：一项监测、流行病学和最终结果（SEER）数据库分析
Medicine (Baltimore). 2025 Aug 8;104(32):e43781. doi: 10.1097/MD.0000000000043781.
2
Parental perspectives on access to paediatric oncology clinical trials and treatment options: A cross-sectional survey.家长对儿童肿瘤学临床试验及治疗选择的看法：一项横断面调查。
Bioinformation. 2024 Dec 31;20(12):1959-1963. doi: 10.6026/9732063002001959. eCollection 2024.
3
The effectiveness and reliability of autologous hematopoietic stem cell transplantation following chemotherapy in managing malignant lymphoma: a meta-analysis.

本文引用的文献

1
Safety and efficacy of combinatorial therapy utilizing myeloablative conditioning and autologous stem cell transplantation, targeted immunotherapy, and reduced intensity conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults with relapsed/refractory mature B-cell non-Hodgkin lymphoma.在复发/难治性成熟B细胞非霍奇金淋巴瘤的儿童、青少年和年轻成人中，采用清髓性预处理和自体干细胞移植、靶向免疫疗法以及减低剂量预处理和异基因干细胞移植的联合疗法的安全性和有效性。
Leuk Lymphoma. 2023 Jan;64(1):234-237. doi: 10.1080/10428194.2022.2133542. Epub 2022 Oct 19.
2
Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation, proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model.在临床前伯基特淋巴瘤（BL）模型中，依鲁替尼显著抑制布鲁顿酪氨酸激酶（BTK）磷酸化、增殖并提高总生存率。
Oncoimmunology. 2018 Oct 11;8(1):e1512455. doi: 10.1080/2162402X.2018.1512455. eCollection 2019.
3
化疗后自体造血干细胞移植治疗恶性淋巴瘤的有效性和可靠性：一项荟萃分析。
Discov Oncol. 2025 Feb 13;16(1):175. doi: 10.1007/s12672-025-01876-x.
4
Use of rituximab in mature, high-grade and advanced-stage pediatric B-lineage non-Hodgkin lymphomas: a systematic review, meta-analysis and the Brazilian reality.利妥昔单抗在成熟、高级别和晚期儿童B细胞系非霍奇金淋巴瘤中的应用：一项系统评价、荟萃分析及巴西实际情况
Front Pediatr. 2025 Jan 20;13:1532274. doi: 10.3389/fped.2025.1532274. eCollection 2025.
5
Comprehensive genomic characterization of hematologic malignancies at a pediatric tertiary care center.一家儿科三级护理中心血液系统恶性肿瘤的综合基因组特征分析
Front Oncol. 2024 Dec 2;14:1498409. doi: 10.3389/fonc.2024.1498409. eCollection 2024.
6
Detecting High-Dose Methotrexate-Induced Brain Changes in Pediatric and Young Adult Cancer Survivors Using [F]FDG PET/MRI: A Pilot Study.利用 [F]FDG PET/MRI 检测儿童和青年期癌症幸存者的大剂量甲氨蝶呤诱导的脑改变：一项初步研究。
J Nucl Med. 2024 Jun 3;65(6):864-871. doi: 10.2967/jnumed.123.266760.
7
STAT3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphoma.STAT3 将激活的酪氨酸激酶信号与间变大细胞淋巴瘤的致癌核心转录调控回路偶联。
Cell Rep Med. 2024 Mar 19;5(3):101472. doi: 10.1016/j.xcrm.2024.101472.
8
Malignant and Benign Head and Neck Tumors of the Pediatric Age: A Narrative Review.儿童期头颈部良恶性肿瘤：一项叙述性综述
Curr Pediatr Rev. 2025;21(2):118-132. doi: 10.2174/0115733963258575231123043807.
9
Editorial: Diagnosis and therapy pediatric hematological malignancies: recent progress.社论：小儿血液系统恶性肿瘤的诊断与治疗：最新进展
Front Pediatr. 2023 Oct 26;11:1303561. doi: 10.3389/fped.2023.1303561. eCollection 2023.
10
Marital status independently predicts the overall survival in young adult patients with lymphoma: A population-based, propensity-matched study.婚姻状况可独立预测青年淋巴瘤患者的总生存：一项基于人群、倾向评分匹配的研究。
Medicine (Baltimore). 2023 Sep 8;102(36):e34416. doi: 10.1097/MD.0000000000034416.
Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study.维布妥昔单抗治疗儿童复发或难治性霍奇金淋巴瘤及间变性大细胞淋巴瘤：一项多中心、开放标签的1/2期研究。
Lancet Haematol. 2018 Oct;5(10):e450-e461. doi: 10.1016/S2352-3026(18)30153-4.
4
UCH-L1 bypasses mTOR to promote protein biosynthesis and is required for MYC-driven lymphomagenesis in mice.UCH-L1 通过绕过 mTOR 促进蛋白质生物合成，并且是小鼠中 MYC 驱动的淋巴瘤发生所必需的。
Blood. 2018 Dec 13;132(24):2564-2574. doi: 10.1182/blood-2018-05-848515. Epub 2018 Sep 26.
5
Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma.循环肿瘤 DNA 测量作为弥漫性大 B 细胞淋巴瘤的早期预后预测指标。
J Clin Oncol. 2018 Oct 1;36(28):2845-2853. doi: 10.1200/JCO.2018.78.5246. Epub 2018 Aug 20.
6
Is the cancer survival improvement in European and American adolescent and young adults still lagging behind that in children?欧美青少年和年轻成年人的癌症存活率改善是否仍落后于儿童？
Pediatr Blood Cancer. 2019 Jan;66(1):e27407. doi: 10.1002/pbc.27407. Epub 2018 Aug 19.
7
Excellent outcomes in children and adolescents with CNS Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1.仅使用鞘内和全身化学免疫疗法治疗中枢神经系统伯基特淋巴瘤或其他成熟B细胞非霍奇金淋巴瘤的儿童和青少年患者取得了优异疗效：来自FAB/LMB96和儿童肿瘤协作组ANHL01P1研究的结果
Br J Haematol. 2019 Apr;185(2):374-377. doi: 10.1111/bjh.15520. Epub 2018 Aug 16.
8
Overall survival of children and adolescents with mature B cell non-Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB/LMB 96: A report from the FAB/LMB 96 study group.FAB/LMB 96 方案治疗期间或治疗后发生难治或复发的成熟 B 细胞非霍奇金淋巴瘤患儿和青少年的总生存：来自 FAB/LMB 96 研究组的报告。
Br J Haematol. 2018 Sep;182(6):859-869. doi: 10.1111/bjh.15491. Epub 2018 Jul 9.
9
NHL in adolescents and young adults: A unique population.青少年和年轻成人中的 NHL：一个独特的群体。
Pediatr Blood Cancer. 2018 Aug;65(8):e27073. doi: 10.1002/pbc.27073. Epub 2018 May 9.
10
Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma.主要组织相容性复合体 II 类和程序性死亡配体 1 表达预测经典霍奇金淋巴瘤接受程序性死亡 1 阻断后的结局。
J Clin Oncol. 2018 Apr 1;36(10):942-950. doi: 10.1200/JCO.2017.77.3994. Epub 2018 Feb 2.